Education patients

Locate the clinical educator in any health care agency in your community whose job it is to do patient education. Discuss with that person his or her thoughts and feelings on patient education, as well as any problems or pitfalls he or she has identified. 

Ms. Watson has diabetes and is taking tolbutamide (Orinase). Her primary care provider prescribes the combination drug sulfamethoxazole and trimethoprim (Septra) for a bladder infection. Discuss any instructions information you would give to Ms. Watson in the patient education session... 

Educating the Patient and Family When an anthelmintic is prescribed on an outpatient basis, the nurse gives the patient or a family member complete instructions about taking the drug, as well as household precautions that should be followed until the helminth is eliminated from the intestine The nurse develops a patient education plan to include the following... 

Although this is not a foolproof remedy for eliminating possible misuse and abuse, thorough patient education can help minimize the risk of problems associated with OTC NSAlDs. 

Ms. Grady, age 48 years, will be discharged in 2 days. The primary health care provider has prescribed propranolol to treat her arrhythmia. Develop a patient educational handout for Ms. Grady to take home with her explaining the most important points for her to know when taking propranolol. 

Monitoring and Managing Adverse Reactions The patient prescribed die female hormones usually takes diem for several months or years. Throughout diat time, die patient must be monitored for adverse reactions (see Ongoing Assessment ). These drugs are self-administered at home This makes patient education an important avenue for detecting and managing adverse reactions. 

An educational, behavior modification approach should be taken with the patient. Education about chemical dependency is most important. Expected behavioral changes must be clearly conceived and communicated to the patient. Evaluation of vocational status and skill development require attention. 

Develop a nonpharmacologic treatment plan which includes patient education for managing heart failure. 

Provide patient education with regard to disease state and drug therapy, and reinforce self-monitoring for symptoms of HF that necessitate follow-up with a health care practitioner. 

Provide patient education regarding disease state, lifestyle modifications, and drug therapy ... 

Provide patient education with regard to CAD, Ml, indications for medications, and potential adverse effects and drug interactions. 

Provide patient education regarding disease state and drug therapy. 

O Antithrombotic therapies require meticulous and systematic monitoring, as well as ongoing patient education. Well-organized anticoagulation management services improve the quality of patient care and reduce the overall cost. 

Given KK s presentation and history, create an appropriate VTE prophylaxis plan including the pharmacologic agent, dose, route and frequency of administration, duration of therapy, monitoring parameters, and patient education. 

Design an appropriate treatment plan for KK. Your plan should include acute and chronic therapy—specify the drug(s), dose(s), route, frequency of administration, and duration of each therapy, as well monitoring parameters, patient education, and follow-up plan. 

How will you manage BA s warfarin therapy Outline a plan including specific dose changes, timing of monitoring, and patient education. 

Identify risk factors for ischemic stroke in a patient and provide the appropriate patient education. 

Fibrates are the most effective triglyceride-lowering agents and also raise HDL cholesterol levels. Combination therapy with a fibrate, particularly gemfibrozil, and a statin has been found to increase the risk for myopathy. Of the 31 rhabdomyolysis deaths reported with cerivastatin use, 12 involved concomitant gemfibrozil.25 Therefore, more frequent monitoring, thorough patient education, and consideration of factors that increase the risk as reviewed previously should be considered. 

Provide patient education in regard to CHD, hyperlipidemia, therapeutic lifestyle modifications, drug therapy, and therapy adherence. 

Develop a patient education plan that fits the patient s needs. Educate about the differences between the asthmatic and normal lung and what happens to the lung during an asthma attack. Counsel the patient on how their medications work and differentiate between longterm control and quick relief medications. 

Prepare a patient-specific self-monitoring plan and review it with the patient. Educate the patient on the signs and symptoms of asthma deterioration and when and how to take rescue actions. 

Provide patient education about the disease state and therapeutic plan ... 

Recommend appropriate monitoring parameters and patient education for selected drug regimens for treating symptoms of IBD. 

Provide patient education on the proper use of aminosalicylate medications and assess regularly for adherence. Include the following ... 

Provide patient education regarding causes of nausea and vomiting, avoidance of triggers, potential complications, therapeutic options, medication adverse effects, and when to seek medical attention. 

Patient education and planning for dialysis should begin at stage 4 CKD, before end-stage renal disease is reached, to allow for time to establish appropriate access for dialysis. 

Patient Education Refer to Table 26-5 for key components of patient education for self-injection. 

Patient monitoring should involve a regular systematic evaluation of efficacy and adverse events, referral to appropriate specialists, and patient education. 

Discuss pertinent patient education points for patients with headache disorders. 

---